Applied ($NASDAQ:AUVI) UV Inc. (APUV) recently reported a loss of -$0.32 per share for the fourth quarter despite revenues of $11.45M. Despite the loss, the company reaffirmed its guidance for fiscal year23 (FY23). APUV is a publicly traded company that develops and manufactures industrial-grade ultraviolet (UV) light sources for commercial and industrial applications. The company’s product portfolio includes both standard and custom-engineered UV lamps, LED modules, and optical components, as well as other related accessories. The negative applied UV GAAP EPS of -$0.32 was a result of higher operating expenses associated with increasing headcount, research and development, and other activities. Despite the net loss, APUV still reported an increase of 3% in revenue for the fourth quarter when compared to the prior year. Despite the mixed results, APUV remains confident in its ability to meet its FY23 outlook. The company is continuing to make investments in R&D and personnel to expand its presence in the UV market and has expressed confidence in its ability to capitalize on future opportunities.
Additionally, APUV is developing new products to meet the rising demands in the industrial-grade UV lighting market. Overall, Applied UV Inc. reported a net loss for the fourth quarter but reaffirmed its outlook for FY23. The company is continuing to make investments in R&D and personnel to expand its presence and capitalize on future opportunities in the industrial-grade UV lighting market.
In the latest earnings report of FY2023 Q2 as of June 30 2021, APPLIED UV reported a total revenue of $11.45M, which was a 68.2% decrease compared to the same period last year. Unfortunately, APPLIED UV still reported a net loss of $2.14M in the quarter, despite the increase in total revenue. On a positive note, APPLIED UV’s total revenue has grown from $1.88M three years ago to $10.84M, showing steady growth over the years. The company also remains committed to their FY23 outlook despite the setback.
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Applied Uv. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Applied Uv. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Applied Uv. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Applied Uv are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
The company’s stock opened at $0.1 and closed at the same amount, a 5.4% drop from its prior closing price of $0.1. Despite the loss and decrease in stock price, the company maintained its outlook for fiscal year 2023, reaffirming their commitment to operational excellence. Applied UV attributed the loss in part to increased expenses associated with being a public company and their continued investment in research and development. The company is confident that its long-term strategy will eventually lead to profitability and further growth. Live Quote…
At GoodWhale, we have conducted a thorough analysis of APPLIED UV‘s fundamentals. According to our Star Chart, we can conclude that APPLIED UV is strong in growth, medium in profitability and weak in asset, dividend. Our analysis classifies APPLIED UV as a ‘cheetah’, which typically refers to companies that achieved high revenue or earnings growth but are considered less stable due to lower profitability. Due to the fact that APPLIED UV is a ‘cheetah’, it is likely to be of interest to investors who are looking for higher growth potential, even at the cost of lower stability. However, investors should note that the company currently has a low health score of 3/10 with regard to its cashflows and debt, meaning that it is less likely to be able to pay off debt and fund future operations. More…
Star Chart Analysis
Its competitors are Healthcare Co Ltd, Signature International Bhd, and Kewaunee Scientific Corp.
The company’s market cap is 4.74B as of 2022. The company’s ROE is -0.51%. The company’s business is providing healthcare services.
– Signature International Bhd ($KLSE:7246)
Signature International Bhd is a Malaysia-based investment holding company. The Company’s segments include Property development, which is engaged in the development of residential and commercial properties; Property investment, which is engaged in the holding of investment properties; Hotel operations, which is engaged in the operations of a hotel; and Others, which include provision of management services and trading of building materials. The Company’s subsidiaries include Signature Properties Sdn. Bhd., which is engaged in property development and investment; Signature Hotel Sdn. Bhd., which is engaged in hotel operations; and Wisma Signature Sdn. Bhd., which is engaged in property investment.
– Kewaunee Scientific Corp ($NASDAQ:KEQU)
Kewaunee Scientific Corporation is a publicly traded company on NASDAQ with the ticker symbol KEQU. The company is based in Statesville, North Carolina and designs, manufactures, and markets scientific equipment for use in research laboratories and pilot plants worldwide. Kewaunee Scientific’s primary product lines are fume hoods, casework, and adaptable modular systems used in a variety of scientific applications. The company also provides related services, including installation and after-market support.
Applied UV is a technology company specializing in UV disinfection solutions. Its stock recently took a hit when the company reported third quarter earnings of negative $0.32 per share on revenue of $11.45 million. Despite this, Applied UV reaffirmed its outlook for the full fiscal year. Despite the lower-than-expected earnings, some analysts are still optimistic about the outlook of the company.
They point to the increasing demand for UV disinfection solutions due to the global health crisis as a potential catalyst for future growth. Given this, it may be worth taking a closer look at Applied UV going forward, especially as a potential long-term investment.